CClinicalTrials.gg
CompletedNCT05052463Updated Sep 28, 2021

Electrolyte Imbalance Analysis at Intensive Care Unit Admission : Retrospective Study

An observational study in Electrolyte Imbalance, sponsored by Kecioren Education and Training Hospital. Completed at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-09-28.

Sponsored by Kecioren Education and Training Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
824
Ages
18 Years and older
Sex
All
01

Study summary

The type and severity of electrolyte imbalance in patients admitted to the intensive care unit were analyzed.It was evaluated whether these results had an effect on mortality, length of hospital stay, APACHE II scores and ventilator days

02

Conditions studied

  • Electrolyte Imbalance
03

In context

Lead sponsor

Kecioren Education and Training Hospital is the lead sponsor of 17 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

ıcu patients

Eligibility criteria

Inclusion Criteria: all of the ıcu patients -

Exclusion Criteria:

-

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
824 participants (actual)
Patient registry
No

Groups and cohorts

  • sodium (hypo-hyper-normonatremia)

    Other: electrolyte imbalance analysis

  • potassium (hypo-hyper-normokalemia)

    Other: electrolyte imbalance analysis

  • calcium (hyper-hypo-normocalcemia)

    Other: electrolyte imbalance analysis

  • magnesium (hyper-hypo-normocalcemia)

    Other: electrolyte imbalance analysis

  • phosphor (hypo-hyper-normophosphatemia)

    Other: electrolyte imbalance analysis

Interventions

  • Otherelectrolyte imbalance analysis

    ın this retrospective study we aimed to evaluate the relationship between the ıcu prognosis and the electrolyte imbalance

06

What researchers measure

Primary outcomes

  1. The analysis the electrolyte imbalance in ICU and the relationship between the icu prognosis.

    Natremia (Hypo: \<136 mmol/L, Normo: 136-145 mmol/L, Hyper: \>145 mmol/L) Kalemia (Hypo: \<3.5 mmol/L, Normo: 3.5-5.5 mmol/L, Hyper: \>5.5 mmol/L) Calcemia (Hypo: \<8.8 mg/dL, Normo: 8.8-10.6 mg/dL, Hyper: \>10.6 mg/dL) Magnesemia (Hypo: \<1.9 mg/dL, Normo: 1.9-2.5 mg/dL, Hyper: \>2.5 mg/dL) Phosphatemia (Hypo: \<2.5 mg/dL, Normo: 2.5-4.5 mg/dL, Hyper: \>4.5 mg/dL) The number of patients in all types of electrolyte imbalance will be determined. The effect of the type of electrolyte imbalance on mortality, APACHE-II score and length of invasive ventilation and hospital stay will be evaluated.

    Time frame: 2 years

07

Study locations

1 site
  • Ankara Kecioren Training and Research Hospital
    Ankara, Çankaya, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 28, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05052463
Lead sponsor
Kecioren Education and Training Hospital
Responsible party
ESRA OZAYAR (Head of Anesthesiology and Reanimation Department, Kecioren Education and Training Hospital) — Principal investigator
First posted
Sep 22, 2021
Start date
Dec 10, 2019
Primary completion
Apr 5, 2021
Completion
Aug 15, 2021
Last update
Sep 28, 2021

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion